Straumann Holding AG ADR QS50
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $11.90
- Day Range
- $11.90–11.90
- 52-Week Range
- $9.45–61.00
- Bid/Ask
- $11.00 / $11.40
- Market Cap
- $18.97 Bil
- Volume/Avg
- 0 / —
Key Statistics
- Price/Earnings (Normalized)
- 40.19
- Price/Sales
- 7.66
- Dividend Yield (Trailing)
- 0.73%
- Dividend Yield (Forward)
- 0.73%
- Total Yield
- 0.83%
Company Profile
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company’s core products are dental implants, and it holds roughly one third of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Growth
- Total Number of Employees
- 11,100
- Website
- https://www.straumann-group.com
Competitors
Valuation
|
Metric
|
QS50
|
XRAY
|
ALGN
|
|---|---|---|---|
Price/Earnings (Normalized) | 40.19 | 14.04 | 28.70 |
Price/Book Value | 9.59 | 1.66 | 5.13 |
Price/Sales | 7.66 | 1.39 | 4.98 |
Price/Cash Flow | 31.91 | 11.50 | 23.38 |
Price/Earnings
QS50
XRAY
ALGN
Financial Strength
|
Metric
|
QS50
|
XRAY
|
ALGN
|
|---|---|---|---|
Quick Ratio | 1.34 | 0.71 | 1.02 |
Current Ratio | 1.95 | 1.43 | 1.23 |
Interest Coverage | 19.50 | −0.45 | — |
Quick Ratio
QS50
XRAY
ALGN
Profitability
|
Metric
|
QS50
|
XRAY
|
ALGN
|
|---|---|---|---|
Return on Assets (Normalized) | 13.05% | 5.31% | 11.78% |
Return on Equity (Normalized) | 23.67% | 11.38% | 19.68% |
Return on Invested Capital (Normalized) | 18.17% | 8.02% | 18.66% |
Return on Assets
QS50
XRAY
ALGN
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Hlsbyssnt | Znfx | $151.0 Bil | |||
| Becton Dickinson & Co
BDX
| Ynndwvks | Vpgdws | $67.5 Bil | |||
| Alcon Inc
ALC
| Llvrmhp | Vrcqnfv | $44.4 Bil | |||
| ResMed Inc
RMD
| Phzgwkbwx | Lbpfyc | $31.1 Bil | |||
| Coloplast A/S ADR
CLPBY
| Tgywqmwqz | Kdxr | $27.6 Bil | |||
| West Pharmaceutical Services Inc
WST
| Xmkfhsrh | Zrx | $24.4 Bil | |||
| The Cooper Companies Inc
COO
| Xtwkhsyb | Jgfcxrg | $18.6 Bil | |||
| Baxter International Inc
BAX
| Ykvkqhvy | Vpdwf | $17.2 Bil | |||
| Hologic Inc
HOLX
| Gwdgxxgg | Kqghmhk | $16.8 Bil | |||
| Teleflex Inc
TFX
| Ymh | Qwpw | $9.8 Bil |